The role of macroelements in the human body;Az esszenciális makrofémionok szerepe az emberi szervezet muködésében

Orvosi Hetilap

Volumn 147, Issue 20, 2006, Pages 925-930

  Lakatos, Béla ^a   Balla, József ^b   Vinkler, Péter ^a   Szentmihályi, Klára ^a,c  

^a Eötvös Loránd Research Network   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c NONE   (Hungary)

Author keywords

Absorption; Antioxidant; Atherosclerosis; Blood pressure; Calcium; Diabetes; Ion channels; Ion exchangers; Ion pumps; Magnesium; Osteoporosis; Potassium; Prooxidant; Sodium; Tumor

Indexed keywords

CALCIUM; CALCIUM ION; ION CHANNEL; MAGNESIUM; MAGNESIUM ION; POTASSIUM; SODIUM; ANTIOXIDANT; CALCIUM CHANNEL; MAGNESIUM DERIVATIVE; OXIDIZING AGENT; POTASSIUM CHANNEL; SODIUM CHANNEL;

ANTIOXIDANT ACTIVITY; CALCIUM METABOLISM; ELECTROLYTE DISTURBANCE; ELECTROLYTE EXCRETION; ELECTROLYTE INTAKE; ELECTROLYTE METABOLISM; ELECTROLYTE TRANSPORT; HOMEOSTASIS AND REGULATION; HUMAN; ION EXCHANGE; MAGNESIUM METABOLISM; POTASSIUM METABOLISM; REVIEW; SODIUM METABOLISM; ACTIVE TRANSPORT; CALCIUM INTAKE; INTESTINE ABSORPTION; ION TRANSPORT; MAGNESIUM DEFICIENCY; METABOLISM; NUTRITIONAL DEFICIENCY; PHYSIOLOGY; POTASSIUM DEFICIENCY; POTASSIUM INTAKE; SODIUM INTAKE;

ANTIOXIDANTS; BIOLOGICAL TRANSPORT, ACTIVE; CALCIUM; CALCIUM CHANNELS; CALCIUM, DIETARY; DEFICIENCY DISEASES; HUMANS; INTESTINAL ABSORPTION; ION CHANNELS; ION TRANSPORT; MAGNESIUM COMPOUNDS; MAGNESIUM DEFICIENCY; OXIDANTS; POTASSIUM CHANNELS; POTASSIUM DEFICIENCY; POTASSIUM, DIETARY; SODIUM; SODIUM CHANNELS; SODIUM, DIETARY;

EID: 33745914641     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Audelin, M. C., Genest, J.: Homocysteine and cardiovascular disease in diabetes mellitus. Atherosclerosis, 2001, 159, 497-511.
2. Aviv, A.: Salt consumption, reactive oxygen species and cardiovascular ageing: a hypothetical link. J. Hypertens., 2002, 20, 555-559.
3. Bánfi, B., Tirone, F., Durussell, I. és mtsai: Mechanism of Ca2+ activation of the NADPH oxidase (NOX5). J. Biol. Chem., 2004, 279, 18553-18591.
4. Bíró Gy.: A magyarországi táplálkozás jellemzoi. Sportorvosi Szemle, 1994, 35, 35-46.
5. Bouillon R., Van Cromphaut, S., Carmeliet, G.: Intestinal calcium absorption: Molecular vitamin D mediated mechanisms. J. Cell Biochem., 2003, 88, 332-339.
6. Chen, R. A., Goodman, W. G.: Role of the calcium-sensing receptor in parathyroid gland physiology. Am. J. Physiol. Renal Physiol., 2004, 286, F1005-F1011.
7. Coggeshall, K. M., Nakamura, K., Phee, H.: How do inhibitory phosphatases work? Mol. Immunol., 2002, 39, 521-529.
8. Cole, D. C., Quamme, G. A.: Inherited disorders of renal magnesium handling. J. Am. Soc. Nephrol., 2000, 11, 1937-1947.
9. Durlach, J.: Magnesium in clinical practice. J. Libbey and Co Ltd., London, 1988, 1-360. old.
10. 2+ redistribution. ABB, 2002, 401, 277-282.
11. Fazekas T., Selmeczi B., Stefanovits P.: A magnézium forrásai és jelentosége az élovilágban. Akadémiai Kiadó, Budapest, 1992, 137-178. old.
12. Fazekas T., Liszkai G.: Kombinált kálium+magnézium terápia cardiovacularis kórképekben. Card. Hung., 2002, 32, 155-160.
13. Ferruzza, S., Scarino, M.L., Rotilio, G. és mtsai: Copper treatment alters the permeability of tight junctions in cultured human intestinal Caco-2 cells. Am. J. Physiol., 1999, 277, G1138-G1148.
14. 2+ on Na-dependent inositol transport. Diabetes, 1992, 91, 35-39.
15. He, F. J., MacGregor, G. A.: A kálium jótékony hatásai. BMJ Magyar Kiadás, 2001, 5-6, 284-288.
16. Iannello, S., Belfiore, F.: Hypomagnesemia. Panminerva Med., 2001, 43, 177-209.
17. Iseri, L. T., French, J. H.: Magnesium natures physiological calcium blocker. Am. Heart. J., 1984, 108, 188-193.
18. Kari, J. A., Farouq, M.: Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Pediatr. Nephrol., 2003, 18, 506-510.
19. Kies, C.: Nutritional bioavailability of calcium. ACS Symp. Ser., 1985, 275, 1-156.
20. Kolch, W.: Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem. J., 2000, 351, 289-305.
21. Kostellow, A. B., Morrill, G. A.: Iron-catalyzed lipid peroxidation in aortic cells in vitro: protective effect of extracellular magnesium. Atherosclerosis, 2004, 175, 15-22.
22. Kumaran, C., Shivakumar, K.: Superoxidemediated activation of cardiac fibroblasts by serum factors in hypomagnesemia, Free Rad. Biol. Med., 2001, 31, 882-886.
23. Lakatos, B.: Magnesium supplementation with acidic polysaccharides. In Magnesium in biological systems. Szerk.: Fazekas, T., Selmeczi, B., Stefanovits, P. Akadémiai Kiadó, Budapest., 1994, 291-300. old.
24. Laurant, P., Touyz, R. M.: Physiological and patophysiological role of magnesium in the cardiovascular system: implications in hypertension. J. Hypertens., 2000, 18, 1177-1191.
25. Lee, J. C., Laydon, J. T, McDonnell, P. C és mtsai: A protein kinase involved in the regulation of inflammatoty cytokine biosynthesis. Nature, 1994, 372, 739-746.
26. Liguori, A., Abete, P., Hayden, J. M. és mtsai: Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type I. Eur. Heart J., 2001, 22, 2075-2084.
27. Malpuech-Brugere, C., Rock, E., Astier, C. és mtsai: Exacerbated immune stress response during experimental magnesium deficiency results from abnormal cell calcium homeostasis. Life Sci., 1998, 63, 1815-1822.
28. Melhem, M. F., Craven, P. A., Liachenko, J. és mtsa: α-Lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes. J. Am. Soc. Nephrol., 2002, 13, 108-116.
29. Mitic, L. L., Van Itallie, C., Anderson, J. M.: Molecular physiology and pathophysiology of tight junction I. Tight junction structure and function: lessons from mutant animals and proteins. Am. J. Physiol. Gastrointest. Liver Physiol., 2000, 279, G250-G254.
30. 2+ modulates membrane lipids in vascular smooth muscle: a link to atherogenesis. FEBS Lett., 1997, 408, 191-194.
31. De Nigris, F., Franconi, F., Maida, F. és mtsai: Modulation by α- and γ-tocopherol of apoptopic signaling induced by oxidized low-density lipoprotein in human coronary smooth muscle cells. Biochem. Pharmacol., 2000, 59, 1477-1487.
32. Norris, W., Kunzelman, K. S., Bussell, S. é mtsai: Potassium supplementation, diet vs pills (A randomized trial in postoperative cardiac surgery patients). CHEST 2004, 125, 404-409.
33. Paolisso, G., Scheen, A., Cozzolino, D. és mtsai: Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J. Clin. Endocrin. Met., 1994, 78, 1510-1514.
34. Park, C. O., Hyun, D. K.: Apoptotic change in response to magnesium therapy after moderate diffuse axonal injury in rats. Yonsei Med. J., 2004, 45, 908-916.
35. Paul, S., Lombroso, P. J.: Receptor and nonreceptor protein tyrosine phosphatases in the nervous system. CMLS Cell. Mol. Life Sci., 2003, 60, 2465-2482.
36. Radó J., Haris Á.: Hyperkalacmiák. Orv. Hetil., 1999, 140, 2611-2618.
37. Rhee, S. G.: Regulation of phosphoinositide-specific phospholipase C. Ann. Rev. Biochem., 2001, 70, 281-312.
38. 2+ accumulation by insulin in rat hearts and cardiac ventricular myocytes. Circ. Res., 2000, 86, 326-333.
39. Schneeberger, E. E., Lynch, R. D.: The tight junction: a multifunctional complex. Am. J. Physiol. Cell Physiol., 2004, 286, C1213-C1228.
40. Serfling, E., Berberich-Siebelt, F., Avots A. és mtsai: NFAT and NF-ΚB-faktors - the distant relatives. Int. J. Biochem. Cell Biol. 2004, 36, 1166-1170.
41. Shaulin, E., Karin, M.: AP-1 as a regulator of cell life and death. Nature Cell Biol., 2002, 4, E131-E136.
42. Siegel, A., Siegel, H.: Compendium on magnesium and its role in biology, nutrition and physiology. Metal Ions Biol. Syst., 1990, 26, 1-771.
43. Shirai, Y., Saito, N.: Activation mechanisms of protein kinase C: mutation, catalytic activation, and targeting. J. Biochem., 2002, 132, 663-668.
44. Siddiqi, S. A., Kuar, S., StHilarie, R. J. és mtsai: Nutrient absorption. Curt. Op. Gastroenterol., 2000, 16, 147-153.
45. Walder, R. Y., Landau, D., Meyer, P. és mtsai: Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nature Genetics, 2002, 31, 171-174.
46. Young, D. B., Lin, H., McCabe, R. D.: Potassium's cardiovascular protective mechanisms. Am. J. Physiol., 1995, 268, R825-R837.
47. Zemel, M. B., Miller, S. L.: Dietary calcium and dairy modulation of adiposity and obesity risk. Nutt. Rev., 2004, 62, 125-131.
48. Zsurka, G., Gregán̂, J., Schweyen, R.: The human mitochondrial Mrs2 protein functionally substitutes for its yeast homologue, a candidate magnesium transporter. Genomics, 2001, 72, 158-168.